Genenta Science S.p.A. Cash and Cash Equivalents, Fair Value Disclosure
Genenta Science S.p.A. (GNTA) had Cash and Cash Equivalents, Fair Value Disclosure of EUR 5.53 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Fair Value Disclosures › Financial Instruments, Financial Assets, Balance Sheet Groupings
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2026-04-01
- 2025-12-31: Cash and Cash Equivalents, Fair Value Disclosure 5.53M EUR.
- 2025-06-30: Cash and Cash Equivalents, Fair Value Disclosure 5.18M EUR.
- 2024-12-31: Cash and Cash Equivalents, Fair Value Disclosure 4.58M EUR.
- 2024-06-30: Cash and Cash Equivalents, Fair Value Disclosure 6.19M EUR.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2025-12-31 | 5.53M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 5.18M EUR 6-K · filed 2025-10-10 |
| 2024-12-31 | 4.58M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 6.19M EUR 6-K · filed 2024-10-29 |
| 2023-12-31 | 3.69M EUR 20-F · filed 2026-04-01 |
| 2022-12-31 | 29.79M EUR 20-F · filed 2025-03-28 |
| 2021-12-31 | 37.24M EUR 20-F · filed 2024-03-29 |